Critical Contrast: BioHarvest Sciences (BHST) & The Competition

BioHarvest Sciences (NASDAQ:BHST) is one of 1,068 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare BioHarvest Sciences to related businesses based on the strength of its valuation, institutional ownership, dividends, earnings, analyst recommendations, risk and profitability.

Analyst Ratings

This is a summary of current ratings for BioHarvest Sciences and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	0	0	2	0	3.00
BioHarvest Sciences Competitors	8148	21805	49613	1310	2.55

BioHarvest Sciences currently has a consensus price target of $13.00, suggesting a potential upside of 136.36%. As a group, “Pharmaceutical preparations” companies have a potential upside of 243.25%. Given BioHarvest Sciences’ peers higher possible upside, analysts clearly believe BioHarvest Sciences has less favorable growth aspects than its peers.

Risk and Volatility

BioHarvest Sciences has a beta of 2.67, meaning that its share price is 167% more volatile than the S&P 500. Comparatively, BioHarvest Sciences’ peers have a beta of 3.67, meaning that their average share price is 267% more volatile than the S&P 500.

Valuation & Earnings

This table compares BioHarvest Sciences and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
BioHarvest Sciences	$12.67 million	-$12.56 million	-4.40
BioHarvest Sciences Competitors	$9.55 billion	$137.66 million	-7.44

BioHarvest Sciences’ peers have higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares BioHarvest Sciences and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-76.65%	N/A	-85.16%
BioHarvest Sciences Competitors	-3,409.82%	-235.83%	-32.89%

Institutional & Insider Ownership

44.1% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 13.6% of shares of all “Pharmaceutical preparations” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

BioHarvest Sciences peers beat BioHarvest Sciences on 8 of the 12 factors compared.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.